TABLE 2.
Treatment | Species or strain | Behavioral outcomes | Molecular mechanisms | Reference |
---|---|---|---|---|
L. rhamnosus (109 cfu daily for 28 days) | Adult male BALB/c mice (10–11 weeks) | ↓ anxiety and depressive-like behavior in OFT, SIH, EPM, fear conditioning (contextual and cued), and FST after L. rhamnosus chronic adnimistration; vagotomy prevented the anxiolytic and antidepressant effects of L. rhamnosus | Changes in expression of GABAAα2 and GABAB1b mRNA after L. rhamnosus chronic administration; vagotomy alone was sufficient to increase GABAAα2 mRNA in the hippocampus but prevented further changes induced by L. rhamnosus | [55] |
B. infantis (daily for 14 days) | Sprague-Dawley rats | no effect on depressive-like behavior | ↓ inflammatory markers (IFN-γ, TNF-α and IL-6 cytokines); ↑ plasma tryptophan and kynurenic acid; ↓concentrations of 5-HIAA (frontal cortex) and DOPAC (amygdaloid cortex) | [58] |
L. rhamnosus (1 × 109 cfu daily for 4 weeks) | male BALB/c mice | ↓ in anxiety and depression-related behaviors | ↑ glutamate + glutamine and ↑ total N-acetyl aspartate + N-acetyl aspartyl glutamic acid at 2 weeks; ↑ GABA at 4 weeks | [50] |
L. brevis FPA 3709 (48-h fermented black soybean milk at a dosage of 35 mg/kg b.w. including 2.5 mg GABA/kg b.w. for 28 days) | Male Sprague-Dawley rats | ↓ in depressive behavior in FST comparable to the effect of fluoxetine | - | [51] |
5-HIAA: 5-Hydroxyindoleacetic Acid; cfu: Colony-Forming Unit; DOPAC: 3,4-Dihydroxyphenylacetic Acid; FST: Forced Swim Test; EPM: Elevated Plus Maze; GABA: Gamma-Aminobutyric Acid; IFN-γ: Interferon Gamma; IL-6: Interleukin-6; OFT; Open Field Test; SIH: Stress-Induced Hyperthermia; TNF-α: Tumor Necrosis Factor Alpha.